心血管疾病患者质量改进策略改善结局研究的评估
该系统综述检索8个电子数据库2009年1月1日至2019年10月25日发表的研究,纳入随机试验和前后对照研究,共456项研究、150148例患者(女性38.1%,男性61.9%;平均[SD]年龄64.6[7.1]岁)。患者支持(311项研究)、健康信息通信技术(78项)、社区支持(18项)、监督(15项)和高强度培训(14项)是最常评估的质量改进策略,其中患者支持、健康信息通信技术、培训和社区支持对临床终点评估最多,并与若干临床结局呈适度关联;群体问题解决与患者自我管理和生活质量改善相关,加强基础设施与治疗满意度改善相关,印刷信息和经济激励未见有意义效果。作者结论认为质量改进策略类型、效果和实施存在实质性差异,需要结局驱动评估和长期研究,尤其在低收入环境。
要点
- 共纳入456项研究、150148例患者,其中427项随机试验、21项准随机研究、8项前后对照研究。
- 患者支持(311项研究)、健康信息通信技术(78项)、社区支持(18项)、监督(15项)和高强度培训(14项)是最常评估的质量改进策略。
- 患者支持、健康信息通信技术、培训和社区支持对临床终点评估最多,并与若干临床结局呈适度关联。
- 群体问题解决与患者自我管理和生活质量改善相关;加强基础设施与治疗满意度改善相关。
- 印刷信息和经济激励未见有意义效果;作者认为需要结局驱动评估和长期研究,尤其在低收入环境。
适用人群与场景
- 已确诊心血管疾病(CVD)的患者,包括心肌梗死后、卒中、心力衰竭人群。
- 研究覆盖45个国家的多种临床环境,目标患者人群多样。
研究设计与关键结果
- 系统综述纳入456项研究、150148例患者(女性38.1%,男性61.9%;平均[SD]年龄64.6[7.1]岁),包括427项随机试验、21项准随机研究和8项前后对照研究。
- 336项研究来自45个国家,其中高收入国家255项(75.9%)、中高收入国家68项(20.2%)、中低收入国家13项(3.9%)、低收入国家0项。
- 患者支持(311项研究)、健康信息通信技术(78项)、社区支持(18项)、监督(15项)和高强度培训(14项)是最常评估的质量改进策略。
- 其他策略包括群体问题解决(7项研究)、印刷信息(5项研究)、加强基础设施(4项研究)和经济激励(3项研究)。
- 患者支持、健康信息通信技术、培训和社区支持对临床终点评估最多,并与若干临床结局呈适度关联。
- 群体问题解决与患者自我管理和生活质量改善相关;加强基础设施与治疗满意度改善相关。
- 印刷信息和经济激励未见有意义效果;其他策略未见结局驱动评估报告。
证据类型、等级与局限
- 证据类型:系统综述,纳入随机试验、准随机研究和前后对照研究。
- 局限性:作者指出质量改进策略的类型、效果和实施存在实质性差异,需要结局驱动评估和长期研究,尤其在低收入环境。
对床旁实践的改变
- 作者认为,本研究所绘制的质量改进策略综合图谱有助于研究者识别改善心血管结局所需的新知识领域。
- 作者认为,需要结局驱动的评估和长期研究,尤其在低收入环境,以更好地理解质量改进策略对心血管疾病预防和控制的效果。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Clinical care quality improvement (QI) strategies are critical to prevent and control cardiovascular disease (CVD). However, there is limited evidence regarding which components of the health system-, clinician-, and patient-based QI strategies contribute to their impact on CVD.
OBJECTIVES: To identify, map, and organize evidence on the effectiveness and implementation of cardiovascular QI strategies that seek to improve outcomes in patients with CVD.
EVIDENCE REVIEW: Eight electronic databases (MEDLINE, EMBASE, CINAHL, PsycINFO, the Cochrane Library, ProQuest, ClinicalTrials.gov, and the World Health Organization International Clinical Trials Registry Platform) were searched for studies published between January 1, 2009, and October 25, 2019. Eligible study designs included randomized trials and preintervention and postintervention evaluations. Descriptive findings of included studies were reported using several frameworks to map the intervention components stratified by target population, setting, outcomes, and overall results.
FINDINGS: From 8066 screened titles and abstracts, 456 unique studies with 150 148 unique patients (38.1% women and 61.9% men; mean [SD] age, 64.6 [7.1] years) were identified, including 427 randomized trials, 21 quasi-randomized studies, and 8 preintervention and postintervention studies. Of 336 studies from 45 countries that were classified, 255 (75.9%) were from high-income countries; 68 (20.2%), upper-middle-income countries; 13 (3.9%), lower-middle-income countries; and 0, low-income countries, with diverse clinical settings and target patient populations (post-myocardial infarction, stroke, heart failure). Patient support (311 studies), information communication technology (ICT) for health (78 studies), community support (18 studies), supervision (15 studies), and high-intensity training (14 studies) were the most commonly evaluated QI strategies. Other strategies were group problem-solving (7 studies), printed information (5 studies), strengthening infrastructure (4 studies), and financial incentives (3 studies). Patient support, ICT for health, training, and community support were strategies that had been evaluated the most for clinical end points and showed modest associations with several clinical outcomes. The other strategies did not have outcome-driven evaluations reported. Group problem-solving was associated with improved patient self-care and quality of life. Strengthening infrastructure was associated with improved treatment satisfaction. Printed information and financial incentives showed no meaningful effect.
CONCLUSIONS AND RELEVANCE: This systematic review found that substantial variations exist in the types, effectiveness, and implementation of QI strategies for patients with CVD. A comprehensive map of QI strategies created by this study would be useful for researchers to identify where new knowledge is needed to improve cardiovascular outcomes. Outcome-driven evaluations and long-term studies are needed, particularly in low-income settings, to better understand the effects of QI strategies on prevention and control of CVD.
参考来源
- Singh K, Bawa VS, Venkateshmurthy NS, et al. Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease. JAMA Netw Open. 2021. PMID: 34125220. doi:10.1001/jamanetworkopen.2021.13375
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。